Floatz logo

IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER

Bile Duct Cancer

National Cancer Institute (NCI)monoclonal_antibodyPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

20 Active assets in the Bile Duct Cancer cohort.

Asset / SponsorPhaseRating
Eloxatin
Lisata Therapeutics, Inc.
Phase 2BB
CIS-DIAMMINEDICHLOROPLATINUM II
Lisata Therapeutics, Inc.
Phase 2BB
Dfn-15
Seoul National University Hospital
Phase 4B
N-BUTYL CYANOACRYLATE
Minia University
Phase 3B
Pembrolizumab
Imugene Limited
Phase 2B

View all 30 →

Same molecule, other indications

IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER is also rated in:

malignant pancreatic neoplasmDormant
BB
Indicative ·
68 / 100
View asset →
Borderline Resectable Pancreatic Ductal AdenocarcinomaDormant
BB
Indicative ·
66 / 100
View asset →
pancreatic ductal adenocarcinomaDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →